Jin Medical International Received Letter From Nasdaq Informing The Company That It Regained Compliance With Filing Requirement In Listing Rule 5250(C) Regarding Filing Of Annual Report
Jin Medical International Received Letter From Nasdaq Informing The Company That It Regained Compliance With Filing Requirement In Listing Rule 5250(C) Regarding Filing Of Annual Report
Jin Medical International收到納斯達克的來信,通知該公司已恢復遵守上市規則5250(C)中關於提交年度報告的申報要求
Jin Medical International Received Letter From Nasdaq Informing The Company That It Regained Compliance With Filing Requirement In Listing Rule 5250(C) Regarding Filing Of Annual Report
Jin Medical International收到納斯達克的來信,通知該公司已恢復遵守上市規則5250(C)中關於提交年度報告的申報要求